Following the outcome of the UK’s referendum on membership of the European Union, the BIA has worked closely with members and stakeholders to identify the threats and opportunities for biotech post-Brexit and to represent the sector.
Our BIA Brexit Briefing webinars will provide a monthly update on government policy, progress of working groups, and how these will potentially affect companies in life sciences – particularly with regards to innovation, financing, regulation and people.
Catch up on last week’s webinar below, delivered by Steve Bates OBE, Chief Executive Officer, BIA.
Visit our website for details on future Brexit webinars.
Do you have a video you would like the sector to see? Contact us.